Treatment of overactive bladder syndrome with urethral calibration in women.
暂无分享,去创建一个
[1] M. Hassouna,et al. Pathophysiology of overactive bladder , 2012, International Urogynecology Journal.
[2] M. Chancellor,et al. Emerging role of botulinum toxin in the management of voiding dysfunction. , 2004, The Journal of urology.
[3] F. Cruz. Mechanisms involved in new therapies for overactive bladder. , 2004, Urology.
[4] M. Chancellor,et al. Current and future pharmacological treatment for overactive bladder. , 2002, The Journal of urology.
[5] V. Nitti. Clinical impact of overactive bladder. , 2002, Reviews in urology.
[6] P. Abrams,et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population‐based prevalence study , 2001, BJU international.
[7] P. Abrams,et al. INTRODUCTION: OVERACTIVE BLADDER AND ITS TREATMENTS , 2000 .
[8] L. Cardozo,et al. A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance , 1997, British journal of obstetrics and gynaecology.
[9] L. Cardozo,et al. Prevalence and significance of urethral instability in women with detrusor instability. , 1993, British journal of urology.
[10] A. Mundy. The treatment of sphincter strictures. , 1989, British journal of urology.
[11] T. Wells,et al. Urinary incontinence in the elderly. , 1989, Seminars in neurology.
[12] M. Karram,et al. Urethral syndrome. A comparison of different treatment modalities. , 1989, The Journal of reproductive medicine.
[13] D. Griffiths,et al. The standardization of terminology of lower urinary tract function. , 1976, European urology.
[14] W E Stevens,et al. STRICTURE OF THE URETHRA IN WOMEN. , 1922, California state journal of medicine.